Oral Presentation 47th Lorne Genome Conference 2026

Mechanisms of chromatin remodelling by MORC family ATPases (132269)

Winnie Tan 1 , Jeongveen Park 2 , Hariprasad Venugopal 3 , Jieqiong Lou 4 , Prabavi Dias 5 , Pedro Baldoni 1 , Kyoung-Wook Moon 2 , Toby Dite 1 , Christine Keenan 1 4 , Alexandra Gurzau 1 , Joonyoung Lee 2 , Timothy Johanson 1 , Andrew Leis 1 , Jumana Yousef 1 , Vineet Vaibhav 1 , Laura Dagley 1 , Ching-Seng Ang 4 , Laura Corso 1 , Chen Davidovich 3 , Stephin Vervoort 1 , Gordon Smyth 1 , Marnie Blewitt 1 , Rhys Allan 1 , Elizabeth Hinde 4 , Sheena D'Arcy 5 , Je-Kyung Ryu 2 , Shabih Shakeel 1 4
  1. The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
  2. Department of Physics and Astronomy, Seoul National University, Seoul, South Korea
  3. Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia
  4. Department of Biochemistry and Pharmacology, The University of Melbourne, Melbourne, VIC, Australia
  5. Department of Chemistry and Biochemistry, The University of Texas, Dallas, Texas, USA

Chromatin-remodelling ATPases of the Microrchidia (MORC) family regulate gene expression through epigenetic silencing. MORC2, the most frequently mutated MORC protein in cancer and neurological disease, remains poorly characterised mechanistically.

Using in vitro biochemical reconstitution, cryo-electron microscopy, single-molecule biophysics and quantitative mass spectrometry, we present the first comprehensive characterisation of full-length MORC2. We reveal that MORC2 contains multiple DNA-binding sites that undergo conformational changes upon DNA engagement and form a DNA clamp via its C-terminal domain (CTD). The CTD harbours a conserved phosphate-interacting motif that regulates ATP hydrolysis and cooperative DNA binding. Through ATP hydrolysis assays and single molecule DNA compaction assays, we demonstrate that MORC2 remodels chromatin via ATP hydrolysis-dependent DNA compaction, a process dynamically tuned by CTD phosphorylation.

These findings establish CTD phosphorylation as a pivotal regulatory mechanism controlling MORC2's chromatin-silencing activity and provide mechanistic insights into how mutations in this protein contribute to disease pathogenesis.